helvy.co.uk

CARDIOVASCULAR HEALTH

Heart Health Blood Test: What to Test & Why Cholesterol Alone Isn't Enough (UK 2026)

Cardiovascular disease kills more people in the UK than any other cause — around 170,000 deaths per year, roughly one every three minutes. Yet most people discover their risk only after a heart attack, stroke, or emergency admission.

The tragedy is that cardiovascular disease is detectable decades before symptoms appear. A single blood test can reveal arterial inflammation, dangerous lipid particle counts, and metabolic dysfunction years before they cause damage — but only if you test the right markers.

This guide covers the blood biomarkers with the strongest evidence for predicting cardiovascular risk — including markers your GP probably won't test unless you're already symptomatic. Based on guidelines from NICE, the European Society of Cardiology, and peer-reviewed research from the UK Biobank.

By Helvy·Medically reviewed by a GMC-registered doctor·16 min read

1. Why a standard cholesterol test isn't enough

For decades, cardiovascular risk assessment has centred on total cholesterol and LDL cholesterol. Your GP checks these, generates a QRISK3 score, and decides whether to prescribe statins.

The problem? This model misses a significant number of people who go on to have cardiovascular events. A landmark 2017 study in the Journal of the American College of Cardiology found that nearly half of heart attacks and strokes occur in people whose LDL cholesterol is within the “normal” range.

Why? Because LDL cholesterol measures the amount of cholesterol inside LDL particles — but it's the number of particles that drives atherosclerosis. Two people with identical LDL-C can have very different particle counts. The one with more small, dense LDL particles has significantly higher risk, even if their cholesterol number looks reassuring.

Modern cardiovascular risk assessment goes beyond cholesterol. Markers like ApoB (particle count), Lp(a) (genetic risk), hs-CRP (inflammation), and HbA1c (metabolic health) paint a far more complete picture — and each one is actionable.

2. What the NHS tests vs what a heart health panel tests

The NHS Health Check (available every 5 years for adults aged 40–74) is valuable but limited. Here's what it typically covers versus a comprehensive heart health panel:

MARKERNHS HEALTH CHECKHEART HEALTH PANEL
Total cholesterol
HDL cholesterol
LDL cholesterol
Triglycerides
TC:HDL ratio
ApoB
Lp(a)
hs-CRP
HbA1cUsually only if diabetic
Homocysteine
Non-HDL cholesterolSometimes calculated

The NHS approach is designed for population-level screening, not individual risk stratification. The five markers it misses — ApoB, Lp(a), hs-CRP, HbA1c, and homocysteine — are precisely the ones that catch risk in people who look “normal” on standard lipids.

3. Lipid markers — the foundation of cardiovascular risk

A standard lipid panel remains essential — it's just not sufficient. These markers form the baseline for understanding how fats move through your blood and into your artery walls.

Total Cholesterol

WHAT IT MEASURES

The sum of all cholesterol in your blood — HDL, LDL, VLDL, and IDL combined. A snapshot of overall lipid status.

OPTIMAL RANGE

Below 5.0 mmol/L (NICE guideline). Below 4.5 mmol/L for those at higher risk.

WHY IT MATTERS FOR YOUR HEART

Total cholesterol alone is a blunt instrument — it can be elevated because of high HDL (protective) or high LDL (harmful). It's useful as a starting point but should never be interpreted in isolation.

LDL Cholesterol

WHAT IT MEASURES

The cholesterol content inside low-density lipoprotein particles. Often called 'bad' cholesterol because LDL particles deposit cholesterol into artery walls.

OPTIMAL RANGE

Below 3.0 mmol/L (general). Below 2.6 mmol/L (performance-oriented). Below 1.8 mmol/L (high CV risk per ESC guidelines).

WHY IT MATTERS FOR YOUR HEART

LDL is the primary target for cardiovascular prevention under NICE CG181 and ESC guidelines. It's the most validated modifiable risk factor — every 1 mmol/L reduction in LDL cuts major cardiovascular events by approximately 22% (CTT Collaboration, The Lancet, 2010).

HDL Cholesterol

WHAT IT MEASURES

High-density lipoprotein cholesterol — the 'good' cholesterol that removes excess cholesterol from artery walls and returns it to the liver for disposal (reverse cholesterol transport).

OPTIMAL RANGE

Above 1.0 mmol/L (men). Above 1.2 mmol/L (women). Above 1.2 mmol/L for optimal cardiovascular protection.

WHY IT MATTERS FOR YOUR HEART

Low HDL is an independent risk factor for cardiovascular disease. The Framingham Heart Study showed that each 0.03 mmol/L increase in HDL is associated with a 2-3% reduction in coronary heart disease risk.

Triglycerides

WHAT IT MEASURES

Fats circulating in your blood, largely influenced by recent carbohydrate and alcohol intake. Elevated triglycerides often signal insulin resistance and metabolic syndrome.

OPTIMAL RANGE

Below 1.7 mmol/L (NICE). Below 1.0 mmol/L (optimal). Fasting sample preferred.

WHY IT MATTERS FOR YOUR HEART

High triglycerides independently predict cardiovascular events (Copenhagen General Population Study, JAMA, 2007). They also drive the formation of small, dense LDL particles — the most atherogenic LDL subtype.

Non-HDL Cholesterol

WHAT IT MEASURES

Total cholesterol minus HDL cholesterol. Captures all atherogenic lipoproteins (LDL + VLDL + IDL + Lp(a)) in a single number.

OPTIMAL RANGE

Below 4.0 mmol/L (general). Below 3.4 mmol/L (moderate risk). Below 2.5 mmol/L (high risk).

WHY IT MATTERS FOR YOUR HEART

NICE CG181 recommends non-HDL as a primary treatment target alongside LDL. It's more accurate than LDL alone because it accounts for triglyceride-rich remnant particles that also damage arteries — and it doesn't require a fasting sample.

4. Advanced markers — ApoB and Lp(a)

These are the markers that transform cardiovascular risk assessment from “probably fine” to “here is your actual risk.” Neither is routinely tested on the NHS, yet both are recommended by the European Society of Cardiology (2019 ESC/EAS Guidelines) for comprehensive risk evaluation.

Apolipoprotein B (ApoB)

WHAT IT MEASURES

The protein on every atherogenic lipoprotein particle — LDL, VLDL, IDL, and Lp(a). One ApoB molecule per particle, so ApoB is a direct count of the particles that cause atherosclerosis.

OPTIMAL RANGE

Below 1.0 g/L (general population). Below 0.8 g/L (high risk). Below 0.65 g/L (very high risk — ESC guideline).

WHY IT MATTERS FOR YOUR HEART

ApoB is a better predictor of cardiovascular events than LDL cholesterol. Two people with identical LDL-C can have very different ApoB levels — the one with more particles has more risk. A 2019 meta-analysis in JAMA Cardiology found ApoB superior to LDL-C and non-HDL-C for predicting major cardiovascular events.

Lipoprotein(a) — Lp(a)

WHAT IT MEASURES

A genetically determined lipoprotein particle similar to LDL but with an additional protein — apolipoprotein(a) — attached. Levels are 80-90% determined by your genes and are largely unresponsive to diet or exercise.

OPTIMAL RANGE

Below 30 nmol/L (low risk). 30-75 nmol/L (moderate risk). Above 75 nmol/L (elevated risk — affects roughly 1 in 5 people).

WHY IT MATTERS FOR YOUR HEART

Lp(a) is one of the most underappreciated cardiovascular risk factors. The European Heart Journal (2019) meta-analysis of over 120,000 participants found that elevated Lp(a) is associated with a 1.5-2x increased risk of coronary heart disease, independent of LDL. You only need to test it once — your levels don't change significantly over time.

WHY THIS MATTERS

If your GP has told you your cholesterol is “fine” but you have a family history of heart disease, ApoB and Lp(a) are the two markers most likely to reveal hidden risk. The ESC now recommends measuring Lp(a) at least once in every adult's lifetime.

5. Inflammation — hs-CRP and the silent driver of plaque

Atherosclerosis is not just a cholesterol problem — it's an inflammatory disease. Cholesterol deposits in artery walls, but it's the inflammatory response that turns stable deposits into the unstable plaques that rupture and cause heart attacks.

hs-CRP (High-Sensitivity C-Reactive Protein)

WHAT IT MEASURES

A marker of low-grade systemic inflammation produced by the liver. Unlike standard CRP (used for acute infections), hs-CRP measures the chronic, low-level inflammation linked to cardiovascular disease.

OPTIMAL RANGE

Below 1.0 mg/L (low cardiovascular risk). 1.0-3.0 mg/L (moderate). Above 3.0 mg/L (high risk — American Heart Association classification).

WHY IT MATTERS FOR YOUR HEART

The JUPITER trial (NEJM, 2008) demonstrated that even people with normal LDL cholesterol but elevated hs-CRP had significantly increased cardiovascular risk — and benefited from treatment. hs-CRP adds predictive power independent of cholesterol levels.

A persistently elevated hs-CRP (>3.0 mg/L) in someone without acute illness suggests chronic inflammation driven by factors like excess visceral fat, poor sleep, chronic stress, ultra-processed diet, or sedentary behaviour. Addressing these root causes often brings hs-CRP below 1.0 mg/L within 3–6 months — measurably reducing cardiovascular risk.

6. Metabolic health — HbA1c and heart disease

Type 2 diabetes roughly doubles your risk of cardiovascular disease — but the damage begins long before a diabetes diagnosis. The pre-diabetic range (HbA1c 42–47 mmol/mol) already carries significantly elevated cardiovascular risk.

HbA1c (Glycated Haemoglobin)

WHAT IT MEASURES

The percentage of haemoglobin bound to glucose over the previous 2-3 months. A long-term picture of blood sugar control — far more reliable than a fasting glucose snapshot.

OPTIMAL RANGE

Below 42 mmol/mol (non-diabetic). 20-34 mmol/mol (optimal metabolic health). 42-47 mmol/mol (pre-diabetic — early intervention window).

WHY IT MATTERS FOR YOUR HEART

The UK Prospective Diabetes Study showed that each 1% reduction in HbA1c is associated with a 14% reduction in heart attacks. But even in non-diabetic ranges, higher HbA1c predicts cardiovascular events — the Atherosclerosis Risk in Communities (ARIC) study found that HbA1c of 39-47 mmol/mol carried 78% higher cardiovascular risk than below 31 mmol/mol.

Testing HbA1c alongside lipids reveals the metabolic context behind your cardiovascular risk. High triglycerides plus elevated HbA1c is a classic pattern of insulin resistance and metabolic syndrome — a pattern the standard NHS Health Check can miss because HbA1c is typically only tested in people already flagged for diabetes.

7. Homocysteine — the overlooked vascular risk factor

Homocysteine is an amino acid produced during methionine metabolism. When it accumulates in the blood, it damages the endothelial lining of blood vessels — creating sites where plaque can form and grow.

Homocysteine

WHAT IT MEASURES

An amino acid intermediate in folate and B12 metabolism. Elevated levels indicate impaired methylation — a fundamental cellular process — and directly damage blood vessel walls.

OPTIMAL RANGE

Below 10 µmol/L (optimal). 10-15 µmol/L (mild elevation). Above 15 µmol/L (elevated — investigate B12, folate, and MTHFR status).

WHY IT MATTERS FOR YOUR HEART

A meta-analysis in JAMA (2002) found that each 5 µmol/L increase in homocysteine is associated with approximately 20% increased risk of coronary heart disease, independent of traditional risk factors. It's one of the most correctable cardiovascular risk factors — often responding to B12, folate, and B6 supplementation.

Homocysteine is particularly important for people with the MTHFR gene variant (roughly 10% of the population have two copies), who have reduced ability to process folate and may need methylated forms (methylfolate and methylcobalamin) rather than standard folic acid and cyanocobalamin.

8. Omega-3 index — protective fats your heart needs

The omega-3 index measures the proportion of EPA and DHA (the two most important omega-3 fatty acids) in your red blood cell membranes. It reflects your long-term omega-3 intake and is one of the few nutritional biomarkers with direct cardiovascular predictive power.

Omega-3 Index

WHAT IT MEASURES

The percentage of EPA + DHA in red blood cell membranes. A stable 120-day average of your omega-3 status — not influenced by a single meal.

OPTIMAL RANGE

8-12% (cardioprotective). 4-8% (intermediate risk). Below 4% (high risk — equivalent to the highest-risk zone for cardiovascular events).

WHY IT MATTERS FOR YOUR HEART

The Framingham Offspring Study found that an omega-3 index above 8% was associated with a 35% lower risk of death from coronary heart disease. A 2021 meta-analysis in the American Journal of Clinical Nutrition confirmed that higher omega-3 index is associated with reduced total mortality and cardiovascular mortality.

9. What to do with your results

A heart health blood test is only valuable if you act on the results. Here is a practical framework for interpreting each marker:

Green zone — all markers optimal

Maintain your current lifestyle. Retest in 12 months to confirm stability. Your results serve as a valuable baseline for future comparison.

Amber zone — one or more markers suboptimal

This is the window where lifestyle interventions are most powerful. Depending on which markers are flagged:

  • High LDL/ApoB: reduce saturated fat, increase soluble fibre (oats, beans, lentils), add plant sterols. Retest at 3 months.
  • Elevated hs-CRP: investigate root cause — excess body fat, poor sleep, chronic stress, ultra-processed diet. Omega-3 supplementation (2–4g EPA+DHA daily) has strong evidence.
  • High HbA1c: reduce refined carbohydrates, increase post-meal walking (even 10 minutes helps), consider time-restricted eating.
  • Elevated homocysteine: supplement with B12, folate (methylfolate if MTHFR+), and B6. Retest at 90 days.
  • Low omega-3 index: increase oily fish intake (2–3 portions per week) or supplement with high-quality fish oil (2g EPA+DHA daily).

Red zone — markers significantly out of range

Discuss with your GP. Significantly elevated ApoB, very high Lp(a), or HbA1c in the diabetic range may warrant medical intervention alongside lifestyle changes. A heart health blood test gives your GP actionable data — most will welcome having ApoB and Lp(a) results that they wouldn't otherwise have ordered.

10. Who should get a heart health blood test?

In an ideal world, everyone would have a cardiovascular baseline from their late 20s. In practice, a heart health blood test is especially important if you:

Cardiovascular disease develops silently over decades. Testing in your 30s or 40s catches problems at the stage where lifestyle changes — not emergency procedures — are the treatment.

11. How often should you test?

BASELINE

Your first comprehensive heart health panel establishes your personal reference ranges. This is the most important test — future tests gain their value from comparison to this baseline.

IF ALL MARKERS ARE OPTIMAL

Retest annually. Cardiovascular risk evolves gradually — annual testing catches drift before it becomes clinical.

IF MAKING LIFESTYLE CHANGES

Retest at 3 months. Lipids and hs-CRP respond measurably to dietary and exercise interventions within 8–12 weeks. HbA1c reflects the previous 2–3 months, so a 90-day retest captures the full effect of changes.

Lp(a) — TEST ONCE

Lp(a) is 80–90% genetically determined and doesn't change significantly with lifestyle. A single measurement tells you whether you carry this genetic risk factor. If elevated, work with your GP on managing compounding risk factors (LDL, blood pressure, smoking).

12. Frequently asked questions

Do I need to fast before a heart health blood test?

Ideally, yes — a 10–12 hour overnight fast gives the most accurate triglyceride and glucose readings. However, LDL, HDL, ApoB, Lp(a), hs-CRP, HbA1c, and homocysteine are not significantly affected by fasting status. If fasting isn't practical, non-fasting results are still clinically useful — the ESC now considers non-fasting lipids acceptable for most risk assessments.

Can I get ApoB and Lp(a) tested on the NHS?

Rarely. Some NHS lipid clinics test ApoB and Lp(a) in patients with familial hypercholesterolaemia or premature cardiovascular disease, but they are not included in routine GP blood tests or the NHS Health Check. If your GP suspects a genetic lipid disorder, they may refer you for specialist testing. Otherwise, a private heart health panel is currently the most reliable way to access these markers in the UK.

What's the difference between LDL cholesterol and ApoB?

LDL cholesterol measures the amount of cholesterol inside LDL particles. ApoB counts the number of atherogenic particles. Two people with identical LDL-C can have very different particle counts — and particle count is the stronger predictor of heart disease. Think of it like traffic: LDL-C tells you how much cargo is on the road, ApoB tells you how many vehicles there are. More vehicles means more collisions with your artery walls.

My GP says my cholesterol is “fine” — should I still get tested?

“Fine” usually means your total cholesterol and LDL are within the reference range. But as discussed in section 1, nearly half of cardiovascular events occur in people with “normal” LDL. ApoB, Lp(a), and hs-CRP catch risk that standard cholesterol tests miss. If you have a family history of heart disease or simply want a complete picture, a heart health panel provides markers your GP doesn't routinely order.

Can lifestyle changes actually improve these markers?

Yes — significantly. LDL and ApoB respond to dietary changes (reducing saturated fat, increasing soluble fibre and plant sterols) within 8–12 weeks. hs-CRP often drops dramatically with weight loss, improved sleep, and omega-3 supplementation. HbA1c improves with reduced refined carbohydrates and regular exercise. The exception is Lp(a), which is genetically determined and largely unresponsive to lifestyle — but knowing your Lp(a) level helps you manage the risk factors you can control more aggressively.

How much does a heart health blood test cost in the UK?

A comprehensive heart health panel with advanced markers (ApoB, Lp(a), hs-CRP, HbA1c) typically costs £80– £200 through private providers in the UK. Our Heart Health panel starts at £89 and includes 13 biomarkers covering standard lipids, advanced particle markers, inflammation, and metabolic health — delivered as a home finger-prick kit with results in 5 days.

Know your cardiovascular risk

Our Heart Health panel (£89) tests 13 biomarkers including ApoB, Lp(a), hs-CRP, and HbA1c — the markers your GP doesn't routinely check. Home finger-prick kit, results in 5 days.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Do not make changes to medication, supplementation, or treatment plans based solely on information in this article — consult your GP or a qualified healthcare professional. All Helvy blood tests are processed by UKAS-accredited NHS laboratories and reviewed by a GMC-registered doctor.

Last updated: April 2026 · By Helvy · Medically reviewed by a GMC-registered doctor